4.1 Article

Isolation and characterization of eight bacteriophages infecting Erwinia amylovora and their potential as biological control agents in British Columbia, Canada

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/07060661.2011.588250

Keywords

bacteriophage; biological control agent; biopesticide; Erwinia amylovora; fire blight

Categories

Funding

  1. Agriculture and Agri-Food Canada
  2. Natural Science and Engineering Research Council of Canada (NSERC)

Ask authors/readers for more resources

Nineteen active bacteriophages against Erwinia amylovora, the causal agent of fire blight, were collected from apple and pear orchards in the Okanagan and Fraser Valleys of British Columbia. Eight survived the isolation, purification and storage processes. Five bacteriophage isolates included in this study lysed more than 50% of the 20 E. amylovora strains tested from BC. Examination by transmission electron microscopy revealed that all eight phages belong to the order Caudovirales, the tailed phages, and included members of the families Myoviridae and Podoviridae. Bacteriophages were characterized by digestion of the phage DNA with four restriction endonucleases and two sets of PCR primers. Two novel groups, RFLP groups 7 and 8, were identified based on differences in restriction fragment patterns. Phages Phi Ea1337-26 and Phi Ea2345-6 reduced infection by 84% and 96%, respectively, when tested on detached pear blossoms using the epiphyte bacterium Pantoea agglomerans Eh21-5 as a carrier. In addition, bacteriophage Phi Ea2345-6, applied in combination with Eh21-5, reduced infection of fire blight on apple flowers of potted apple trees by 56% and compared well with the antibiotic streptomycin.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Engineering, Biomedical

In vivo fluorescence imaging of biomaterial-associated inflammation and infection in a minimally invasive manner

Shalu Suri, Susan M. Lehman, Shivaram Selvam, Khalilah Reddie, Santanu Maity, Niren Murthy, Andres J. Garcia

JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2015)

Letter Cardiac & Cardiovascular Systems

Novel bacteriophage therapy for treatment of left ventricular assist device infection

Saima Aslam, Victor Pretorius, Susan M. Lehman, Sandra Morales, Robert T. Schooley

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2019)

Article Virology

Design and Preclinical Development of a Phage Product for the Treatment of Antibiotic-Resistant Staphylococcus aureus Infections

Susan M. Lehman, Gillian Mearns, Deborah Rankin, Robert A. Cole, Frenk Smrekar, Steven D. Branston, Sandra Morales

VIRUSES-BASEL (2019)

Article Infectious Diseases

Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient

Nancy Law, Cathy Logan, Gordon Yung, Carrie-Lynn Langlais Furr, Susan M. Lehman, Sandra Morales, Francisco Rosas, Alexander Gaidamaka, Igor Bilinsky, Paul Grint, Robert T. Schooley, Saima Aslam

INFECTION (2019)

Article Surgery

Early clinical experience of bacteriophage therapy in 3 lung transplant recipients

Saima Aslam, Andrew M. Courtwright, Christine Koval, Susan M. Lehman, Sandra Morales, Carrie-Lynn Langlais Furr, Francisco Rosas, Michael J. Brownstein, Joseph R. Fackler, Brittany M. Sisson, Biswajit Biswas, Matthew Henry, Truong Luu, Brittany N. Bivens, Theron Hamilton, Christopher Duplessis, Cathy Logan, Nancy Law, Gordon Yung, Jason Turowski, Judith Anesi, Steffanie A. Strathdee, Robert T. Schooley

AMERICAN JOURNAL OF TRANSPLANTATION (2019)

Article Microbiology

Bacteriophage-Antibiotic Combination Strategy: an Alternative against Methicillin-Resistant Phenotypes of Staphylococcus aureus

Razieh Kebriaei, Katherine Lev, Taylor Morrisette, Kyle C. Stamper, Jacinda C. Abdul-Matakabbir, Susan M. Lehman, Sandra Morales, Michael J. Rybak

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)

Article Microbiology

Bacteriophage-Antibiotic Combinations for Enterococcus faecium with Varying Bacteriophage and Daptomycin Susceptibilities

Taylor Morrisette, Katherine L. Lev, Razieh Kebriaei, Jacinda C. Abdul-Mutakabbir, Kyle C. Stamper, Sandra Morales, Susan M. Lehman, Gregory S. Canfield, Breck A. Duerkop, Cesar A. Arias, Michael J. Rybak

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)

Article Microbiology

Bacteriophage AB-SA01 Cocktail in Combination with Antibiotics against MRSA-VISA Strain in an In Vitro Pharmacokinetic/Pharmacodynamic Model

Razieh Kebriaei, Katherine L. Lev, Kyle C. Stamper, Susan M. Lehman, Sandra Morales, Michael J. Rybak

Summary: This study proved the effectiveness of bacteriophage-antibiotic combinations in preventing bacteriophage resistance and enhancing bacterial eradication in simulated endocardial vegetation models, potentially combating serious MRSA infections.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

Article Virology

Bacterial Viruses Subcommittee and Archaeal Viruses Subcommittee of the ICTV: update of taxonomy changes in 2021

Mart Krupovic, Dann Turner, Vera Morozova, Mike Dyall-Smith, Hanna M. Oksanen, Rob Edwards, Bas E. Dutilh, Susan M. Lehman, Alejandro Reyes, Diana P. Baquero, Matthew B. Sullivan, Jumpei Uchiyama, Jesca Nakavuma, Jakub Barylski, Mark J. Young, Shishen Du, Poliane Alfenas-Zerbini, Alla Kushkina, Andrew M. Kropinski, Ipek Kurtboke, J. Rodney Brister, Cedric Lood, B. L. Sarkar, Tong Yigang, Ying Liu, Li Huang, Johannes Wittmann, Nina Chanishvili, Leonardo J. van Zyl, Janis Rumnieks, Tomohiro Mochizuki, Matti Jalasvuori, Ramy K. Aziz, Malgorzata Lobocka, Kenneth M. Stedman, Andrey N. Shkoporov, Annika Gillis, Xu Peng, Francois Enault, Petar Knezevic, Rob Lavigne, Sung-Keun Rhee, Virginija Cvirkaite-Krupovic, Cristina Moraru, Andrea I. Moreno Switt, Minna M. Poranen, Andrew Millard, David Prangishvili, Evelien M. Adriaenssens

Summary: The Bacterial Viruses Subcommittee and the Archaeal Viruses Subcommittee of the International Committee on Taxonomy of Viruses (ICTV) summarized their activities from March 2020 to March 2021, reporting the separation of the former Subcommittee into two separate entities and the creation or redefinition of numerous new taxa, including a new realm, three orders, 15 families, 31 subfamilies, 734 genera, and 1845 species.

ARCHIVES OF VIROLOGY (2021)

Article Microbiology

Evaluation of Bacteriophage Cocktails Alone and in Combination with Daptomycin against Daptomycin-Nonsusceptible Enterococcus faecium

Taylor Morrisette, Katherine L. Lev, Gregory S. Canfield, Breck A. Duerkop, Razieh Kebriaei, Kyle C. Stamper, Dana Holger, Susan M. Lehman, Smaranda Willcox, Cesar A. Arias, Michael J. Rybak

Summary: Enterococcus faecium is an important multidrug-resistant pathogen. The use of bacteriophage cocktails as a complement to antibiotic therapy has been proposed. This study selected two phages (113 and 9184) with the broadest host ranges for further experiments and found that the combination of Daptomycin and the phage cocktail showed bactericidal activity and prevented phage resistance against daptomycin-nonsusceptible E. faecium.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)

Article Biotechnology & Applied Microbiology

Bacteriophage-antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa: In vitro synergy testing

Dana J. Holger, Katherine L. Lev, Razieh Kebriaei, Taylor Morrisette, Rahi Shah, Jose Alexander, Susan M. Lehman, Michael J. Rybak

Summary: This study investigates the impact of phage-antibiotic combinations (PAC) on bacterial killing, resistance development, and outer membrane vesicle (OMV) production in multidrug-resistant (MDR) P. aeruginosa. The findings suggest that PAC has the potential to augment killing of MDR P. aeruginosa, prevent resistance development, and reduce OMV production.

JOURNAL OF APPLIED MICROBIOLOGY (2022)

Article Microbiology

Eradication of Biofilm-Mediated Methicillin-Resistant Staphylococcus aureus Infections In Vitro: Bacteriophage-Antibiotic Combination

Razieh Kebriaei, Katherine L. Lev, Rahi M. Shah, Kyle C. Stamper, Dana J. Holger, Taylor Morrisette, Ashlan J. Kunz Coyne, Susan M. Lehman, Michael J. Rybak

Summary: Bacterial biofilms are difficult to eradicate and can complicate infections. Phage+antibiotic combinations (PAC) may be more effective on biofilms than single agents. Our study demonstrated the effectiveness of phage Sb-1 on MRSA biofilms and suggested PAC regimens as adjuncts to antibiotics.

MICROBIOLOGY SPECTRUM (2022)

Article Immunology

Development of Host Immune Response to Bacteriophage in a Lung Transplant Recipient on Adjunctive Phage Therapy for a Multidrug-Resistant Pneumonia

Jennifer M. Dan, Susan M. Lehman, Rita Al-kolla, Samuel Penziner, Kamyar Afshar, Gordon Yung, Eugene Golts, Nancy Law, Cathy Logan, Zsuzsanna Kovach, Gill Mearns, Robert T. Schooley, Saima Aslam, Shane Crotty

Summary: Bacteriophage therapy involves using viruses to kill antibiotic-resistant bacteria. In this case study, we observed the development of phage-specific CD4 T cells, immunoglobulin G, and neutralizing antibodies in response to bacteriophage therapy for a lung transplant recipient with multidrug-resistant Pseudomonas aeruginosa pneumonia. Despite the development of phage-specific immune responses, the treatment was considered successful. We provide a detailed profile of the immune responses in this case.

JOURNAL OF INFECTIOUS DISEASES (2023)

Article Microbiology

Ciprofloxacin in combination with bacteriophage cocktails against multi-drug resistant Pseudomonas aeruginosa in ex vivo simulated endocardial vegetation models

Amer El Ghali, Kyle Stamper, Ashlan J. Kunz Coyne, Dana Holger, Razieh Kebriaei, Jose Alexander, Susan M. Lehman, Michael J. Rybak

Summary: This study evaluated the activity of phage-ciprofloxacin combinations against drug-resistant P. aeruginosa. The results showed that CIP-LL-EC-109 combination therapy had synergistic and bactericidal activity and mitigated phage resistance in an ex vivo simulated endocardial vegetation model.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2023)

Article Immunology

Development of Host Immune Response to Bacteriophage in a Lung Transplant Recipient on Adjunctive Phage Therapy for a Multidrug-Resistant Pneumonia

Jennifer M. Dan, Susan M. Lehman, Rita Al-Kolla, Samuel Penziner, Kamyar Afshar, Gordon Yung, Eugene Golts, Nancy Law, Cathy Logan, Zsuzsanna Kovach, Gill Mearns, Robert T. Schooley, Saima Aslam, Shane Crotty

Summary: This study reported a case of successful treatment of multidrug-resistant Pseudomonas aeruginosa pneumonia in a lung transplant recipient using phage therapy. The development of phage-specific immune response was observed.

JOURNAL OF INFECTIOUS DISEASES (2022)

No Data Available